HEADER METAL BINDING PROTEIN 20-OCT-06 2NLN TITLE SOLUTION STRUCTURE OF CALCIUM-FREE RAT BETA-PARVALBUMIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ONCOMODULIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: OM, PARVALBUMIN BETA; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: OCM; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5ALPHA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBLUESCRIPT KEYWDS CALCIUM-BINDING PROTEIN, RAT BETA PARVALBUMIN, RAT ONCOMODULIN, METAL KEYWDS 2 BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR M.T.HENZL REVDAT 3 16-MAR-22 2NLN 1 REMARK REVDAT 2 24-FEB-09 2NLN 1 VERSN REVDAT 1 11-SEP-07 2NLN 0 JRNL AUTH M.T.HENZL,J.J.TANNER JRNL TITL SOLUTION STRUCTURE OF CA2+-FREE RAT BETA-PARVALBUMIN JRNL TITL 2 (ONCOMODULIN). JRNL REF PROTEIN SCI. V. 16 1914 2007 JRNL REFN ISSN 0961-8368 JRNL PMID 17766386 JRNL DOI 10.1110/PS.072837307 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMR, CNS 1.1 REMARK 3 AUTHORS : VARIAN (VNMR), BRUNGER, A.T. ET AL. (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURES ARE BASED ON A TOTAL OF REMARK 3 2961 RESTRAINTS: 2553 ARE NOE-DERIVED DISTANCE CONSTRAINTS, 241 REMARK 3 ARE DIHEDRAL ANGLE RESTRAINTS, 74 ARE DISTANCE RESTRAINTS REMARK 3 DERIVED FROM PUTATIVE HYDROGEN BONDS, AND 93 ARE ANGLE REMARK 3 RESTRAINTS BASED ON RESIDUAL DIPOLAR COUPLINGS REMARK 4 REMARK 4 2NLN COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-OCT-06. REMARK 100 THE DEPOSITION ID IS D_1000040014. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 0.15 M NACL, 0.01 M MES REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 4 MM ONCOMODULIN, U-15N, 0.15 M REMARK 210 NACL, 0.01 M MES, PH 6.0, 90% REMARK 210 H2O, 10% D2O; 4 MM ONCOMODULIN, REMARK 210 U-15N, 13C, 0.15 M NACL, 0.01 M REMARK 210 MES, PH 6.0, 90% H2O, 10% D2O; 4 REMARK 210 MM ONCOMODULIN, U-15N, 0.15 M REMARK 210 NACL, 0.01 M MES, PH 6.0, 13 MG/ REMARK 210 ML PF1 BACTERIOPHAGE, 90% H2O, REMARK 210 10% D2O; 4 MM ONCOMODULIN, U-15N, REMARK 210 0.15 M NACL, 0.01 M MES, PD 6.2, REMARK 210 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY; 15N-IPAP-HSQC; REMARK 210 15N-HSQC; HNHA REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, SPARKY, ARIA 2.0A, CNS REMARK 210 1.1 REMARK 210 METHOD USED : SIMULATED ANNEALING USING REMARK 210 TORSION ANGLE MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING: 1. DISTANCE REMARK 210 RESTRAINTS COLLECTED FROM 3D NOESY EXPERIMENTS, 2. DIHEDRAL REMARK 210 ANGLE RESTRAINTS BASED ON COUPLING CONSTANTS (HNHA), AND REMARK 210 CHEMICAL SHIFT DATA (CSI, TALOS), 3. HYDROGEN-BOND RESTRAINTS REMARK 210 (COLLECTED FROM H-D EXCHANGE MEASUREMENTS), 4. 1H-15N RESIDUAL REMARK 210 DIPOLAR COUPLINGS REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLY A 98 H PHE A 102 1.53 REMARK 500 O ILE A 46 H PHE A 49 1.55 REMARK 500 O ALA A 12 H GLN A 16 1.55 REMARK 500 O THR A 82 H MET A 86 1.57 REMARK 500 O VAL A 43 H PHE A 47 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ILE A 2 -42.08 -166.74 REMARK 500 1 GLU A 17 -73.29 -61.88 REMARK 500 1 ASP A 20 163.49 172.35 REMARK 500 1 ASP A 22 -6.49 157.44 REMARK 500 1 PHE A 24 73.99 137.63 REMARK 500 1 LYS A 37 49.80 -143.72 REMARK 500 1 PHE A 47 -38.82 -34.85 REMARK 500 1 ILE A 50 -144.78 -63.70 REMARK 500 1 ASP A 53 -47.34 172.43 REMARK 500 1 GLN A 54 -55.14 64.94 REMARK 500 1 SER A 55 31.60 -151.74 REMARK 500 1 SER A 72 40.96 20.34 REMARK 500 1 ASP A 73 18.28 -159.67 REMARK 500 1 ALA A 74 172.26 -55.70 REMARK 500 1 GLU A 76 44.02 86.74 REMARK 500 1 LEU A 77 27.36 32.58 REMARK 500 1 THR A 78 -169.63 37.03 REMARK 500 1 ALA A 89 -86.81 -164.61 REMARK 500 1 ASP A 94 -28.27 -175.78 REMARK 500 2 ILE A 2 -34.90 86.82 REMARK 500 2 GLU A 17 -74.63 -67.88 REMARK 500 2 ASP A 20 168.80 173.10 REMARK 500 2 ASP A 22 -14.82 171.01 REMARK 500 2 PHE A 24 76.16 147.22 REMARK 500 2 LYS A 37 57.74 -148.81 REMARK 500 2 PHE A 47 -36.45 -39.14 REMARK 500 2 ILE A 50 -135.12 -65.32 REMARK 500 2 GLN A 54 -61.32 -151.04 REMARK 500 2 SER A 55 43.72 -149.56 REMARK 500 2 GLN A 71 -74.99 -82.20 REMARK 500 2 SER A 72 17.49 110.31 REMARK 500 2 ASP A 73 28.34 -158.45 REMARK 500 2 GLU A 76 38.39 90.80 REMARK 500 2 LEU A 77 31.09 32.43 REMARK 500 2 THR A 78 -177.01 36.18 REMARK 500 2 ALA A 89 -72.56 -162.63 REMARK 500 2 ASP A 90 53.84 -64.49 REMARK 500 2 ASP A 94 -83.81 -174.08 REMARK 500 2 HIS A 107 -71.76 -80.69 REMARK 500 3 ILE A 2 -107.36 81.27 REMARK 500 3 GLU A 17 -71.99 -61.47 REMARK 500 3 ASP A 20 162.49 173.48 REMARK 500 3 ASP A 22 -2.46 162.55 REMARK 500 3 PHE A 24 77.93 138.78 REMARK 500 3 SER A 36 -26.98 -38.00 REMARK 500 3 LYS A 37 -27.59 -141.33 REMARK 500 3 ASP A 51 129.88 18.58 REMARK 500 3 ASN A 52 43.72 -87.54 REMARK 500 3 SER A 55 36.02 -147.05 REMARK 500 3 GLN A 71 -81.23 -83.39 REMARK 500 REMARK 500 THIS ENTRY HAS 384 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2NLN A 1 108 UNP P02631 ONCO_RAT 1 108 SEQRES 1 A 108 SER ILE THR ASP ILE LEU SER ALA GLU ASP ILE ALA ALA SEQRES 2 A 108 ALA LEU GLN GLU CYS GLN ASP PRO ASP THR PHE GLU PRO SEQRES 3 A 108 GLN LYS PHE PHE GLN THR SER GLY LEU SER LYS MET SER SEQRES 4 A 108 ALA SER GLN VAL LYS ASP ILE PHE ARG PHE ILE ASP ASN SEQRES 5 A 108 ASP GLN SER GLY TYR LEU ASP GLY ASP GLU LEU LYS TYR SEQRES 6 A 108 PHE LEU GLN LYS PHE GLN SER ASP ALA ARG GLU LEU THR SEQRES 7 A 108 GLU SER GLU THR LYS SER LEU MET ASP ALA ALA ASP ASN SEQRES 8 A 108 ASP GLY ASP GLY LYS ILE GLY ALA ASP GLU PHE GLN GLU SEQRES 9 A 108 MET VAL HIS SER HELIX 1 1 ILE A 2 LEU A 6 5 5 HELIX 2 2 SER A 7 GLU A 17 1 11 HELIX 3 3 PHE A 24 GLY A 34 1 11 HELIX 4 4 LEU A 35 MET A 38 5 4 HELIX 5 5 SER A 39 ARG A 48 1 10 HELIX 6 6 ASP A 61 LYS A 64 5 4 HELIX 7 7 TYR A 65 GLN A 71 1 7 HELIX 8 8 LEU A 77 ASP A 87 1 11 HELIX 9 9 GLY A 98 SER A 108 1 11 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 MODEL 2 MODEL 3 MODEL 4 MODEL 5 MODEL 6 MODEL 7 MODEL 8 MODEL 9 MODEL 10 MODEL 11 MODEL 12 MODEL 13 MODEL 14 MODEL 15 MODEL 16 MODEL 17 MODEL 18 MODEL 19 MODEL 20